BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 24204274)

  • 1. A Trypanosoma brucei kinesin heavy chain promotes parasite growth by triggering host arginase activity.
    De Muylder G; Daulouède S; Lecordier L; Uzureau P; Morias Y; Van Den Abbeele J; Caljon G; Hérin M; Holzmuller P; Semballa S; Courtois P; Vanhamme L; Stijlemans B; De Baetselier P; Barrett MP; Barlow JL; McKenzie AN; Barron L; Wynn TA; Beschin A; Vincendeau P; Pays E
    PLoS Pathog; 2013 Oct; 9(10):e1003731. PubMed ID: 24204274
    [TBL] [Abstract][Full Text] [Related]  

  • 2.
    Nzoumbou-Boko R; De Muylder G; Semballa S; Lecordier L; Dauchy FA; Gobert AP; Holzmuller P; Lemesre JL; Bras-Gonçalves R; Barnabé C; Courtois P; Daulouède S; Beschin A; Pays E; Vincendeau P
    J Immunol; 2017 Sep; 199(5):1762-1771. PubMed ID: 28739879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Mouse strain susceptibility to trypanosome infection: an arginase-dependent effect.
    Duleu S; Vincendeau P; Courtois P; Semballa S; Lagroye I; Daulouède S; Boucher JL; Wilson KT; Veyret B; Gobert AP
    J Immunol; 2004 May; 172(10):6298-303. PubMed ID: 15128819
    [TBL] [Abstract][Full Text] [Related]  

  • 4. L-Arginine availability modulates local nitric oxide production and parasite killing in experimental trypanosomiasis.
    Gobert AP; Daulouede S; Lepoivre M; Boucher JL; Bouteille B; Buguet A; Cespuglio R; Veyret B; Vincendeau P
    Infect Immun; 2000 Aug; 68(8):4653-7. PubMed ID: 10899869
    [TBL] [Abstract][Full Text] [Related]  

  • 5. IL-10 dampens TNF/inducible nitric oxide synthase-producing dendritic cell-mediated pathogenicity during parasitic infection.
    Guilliams M; Movahedi K; Bosschaerts T; VandenDriessche T; Chuah MK; Hérin M; Acosta-Sanchez A; Ma L; Moser M; Van Ginderachter JA; Brys L; De Baetselier P; Beschin A
    J Immunol; 2009 Jan; 182(2):1107-18. PubMed ID: 19124754
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Identification of a parasitic immunomodulatory protein triggering the development of suppressive M1 macrophages during African trypanosomiasis.
    Gómez-Rodríguez J; Stijlemans B; De Muylder G; Korf H; Brys L; Berberof M; Darji A; Pays E; De Baetselier P; Beschin A
    J Infect Dis; 2009 Dec; 200(12):1849-60. PubMed ID: 19911988
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Alternative versus classical macrophage activation during experimental African trypanosomosis.
    Baetselier PD; Namangala B; Noël W; Brys L; Pays E; Beschin A
    Int J Parasitol; 2001 May; 31(5-6):575-87. PubMed ID: 11334945
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Mutual self-defence: the trypanolytic factor story.
    Pays E; Vanhollebeke B
    Microbes Infect; 2008 Jul; 10(9):985-9. PubMed ID: 18675374
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Role for parasite genetic diversity in differential host responses to Trypanosoma brucei infection.
    Morrison LJ; McLellan S; Sweeney L; Chan CN; MacLeod A; Tait A; Turner CM
    Infect Immun; 2010 Mar; 78(3):1096-108. PubMed ID: 20086091
    [TBL] [Abstract][Full Text] [Related]  

  • 10. The induction of a type 1 immune response following a Trypanosoma brucei infection is MyD88 dependent.
    Drennan MB; Stijlemans B; Van den Abbeele J; Quesniaux VJ; Barkhuizen M; Brombacher F; De Baetselier P; Ryffel B; Magez S
    J Immunol; 2005 Aug; 175(4):2501-9. PubMed ID: 16081822
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Adenylate cyclases of Trypanosoma brucei inhibit the innate immune response of the host.
    Salmon D; Vanwalleghem G; Morias Y; Denoeud J; Krumbholz C; Lhommé F; Bachmaier S; Kador M; Gossmann J; Dias FB; De Muylder G; Uzureau P; Magez S; Moser M; De Baetselier P; Van Den Abbeele J; Beschin A; Boshart M; Pays E
    Science; 2012 Jul; 337(6093):463-6. PubMed ID: 22700656
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Crystal structure of an arginase-like protein from Trypanosoma brucei that evolved without a binuclear manganese cluster.
    Hai Y; Kerkhoven EJ; Barrett MP; Christianson DW
    Biochemistry; 2015 Jan; 54(2):458-71. PubMed ID: 25536859
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Comparative analysis of antibody responses against HSP60, invariant surface glycoprotein 70, and variant surface glycoprotein reveals a complex antigen-specific pattern of immunoglobulin isotype switching during infection by Trypanosoma brucei.
    Radwanska M; Magez S; Michel A; Stijlemans B; Geuskens M; Pays E
    Infect Immun; 2000 Feb; 68(2):848-60. PubMed ID: 10639455
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Using T. brucei as a biological epitope-display platform to elicit specific antibody responses.
    Stavropoulos P; Papavasiliou FN
    J Immunol Methods; 2010 Oct; 362(1-2):190-4. PubMed ID: 20800596
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The CD20 homolog Ms4a8a integrates pro- and anti-inflammatory signals in novel M2-like macrophages and is expressed in parasite infection.
    Schmieder A; Schledzewski K; Michel J; Schönhaar K; Morias Y; Bosschaerts T; Van den Bossche J; Dorny P; Sauer A; Sticht C; Géraud C; Waibler Z; Beschin A; Goerdt S
    Eur J Immunol; 2012 Nov; 42(11):2971-82. PubMed ID: 22806454
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Haptoglobin-hemoglobin receptor independent killing of African trypanosomes by human serum and trypanosome lytic factors.
    Bullard W; Kieft R; Capewell P; Veitch NJ; Macleod A; Hajduk SL
    Virulence; 2012; 3(1):72-6. PubMed ID: 22286709
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Nitric oxide-mediated suppression of T cell responses during Trypanosoma brucei infection: soluble trypanosome products and interferon-gamma are synergistic inducers of nitric oxide synthase.
    Sternberg MJ; Mabbott NA
    Eur J Immunol; 1996 Mar; 26(3):539-43. PubMed ID: 8605918
    [TBL] [Abstract][Full Text] [Related]  

  • 18. T-Cell responses during Trypanosoma brucei infections in mice deficient in inducible nitric oxide synthase.
    Millar AE; Sternberg J; McSharry C; Wei XQ; Liew FY; Turner CM
    Infect Immun; 1999 Jul; 67(7):3334-8. PubMed ID: 10377110
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Trypanosoma brucei brucei oligopeptidase B null mutants display increased prolyl oligopeptidase-like activity.
    Kangethe RT; Boulangé AF; Coustou V; Baltz T; Coetzer TH
    Mol Biochem Parasitol; 2012; 182(1-2):7-16. PubMed ID: 22123425
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Differential invasion of Trypanosoma brucei brucei and lymphocytes into the brain of C57BL/6 and 129Sv/Ev mice.
    Masocha W; Amin DN; Kristensson K; Rottenberg ME
    Scand J Immunol; 2008 Nov; 68(5):484-91. PubMed ID: 18822108
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.